Novartis's CIBA Vision division has reached a global settlement with Johnson & Johnson Vision Care to license CIBA's ?Nicholson' patents for silicone hydrogel contact lens technology. The terms of the agreement are confidential. The settlement ends ongoing litigation in the U.S. as well as several European countries.
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.